NCT04101630Active, not recruiting
Activity Monitoring in Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
This is a prospective, longitudinal, observational study of free-living activity trackers and patient reported outcomes to test the hypothesis that daily activity will have stronger prognostic value than 6MWD in patients with pulmonary hypertension after 12 weeks.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 230 (estimated)
- First submitted
- 16 Sept 2019
- Start date
- 24 Oct 2019
- Primary completion date
- Dec 2027
- Lead sponsor
- Vanderbilt University Medical Center
- NCT number
- NCT04101630
What you commit to
- Study type: Observational
- Planned participants: 230
- From 24 Oct 2019 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Hospitalization within the prior 3 months
Other
- Pregnancy
- Orthopedic limitations that preclude 6MWD testing
Who the study is looking for
- Enrolled in L-PVDOMICS or
- Any patient in the United States with pulmonary hypertension confirmed by hemodynamics and expert clinical diagnosis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.